NASDAQ · ACHC
Healthcare · Medical - Care Facilities
$31.67
Up+$1.44 (+4.76%)
Updated Oct 15, 2026, 4:18 AM
SID Score
6.2/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · ACHC
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 14, 2026
ACHC closed at $31.67 after 21 trading sessions, up 12.46% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 14, 2026 | $29.84 | $31.895 | $29.84 | $31.67 | 1.93M |
| Oct 13, 2026 | $30.20 | $30.80 | $29.59 | $30.23 | 1.27M |
| Oct 12, 2026 | $29.10 | $30.21 | $29.07 | $30.08 | 1.21M |
| Oct 9, 2026 | $28.31 | $29.45 | $28.31 | $29.25 | 1.38M |
| Oct 8, 2026 | $28.86 | $29.0631 | $28.39 | $28.48 | 1.3M |
| Oct 7, 2026 | $28.84 | $29.655 | $28.66 | $29.23 | 1.65M |
| Oct 6, 2026 | $28.835 | $29.255 | $28.43 | $29.04 | 1.42M |
| Oct 5, 2026 | $28.32 | $28.92 | $27.83 | $28.87 | 2.43M |
| Oct 2, 2026 | $27.27 | $28.32 | $26.76 | $28.06 | 1.44M |
| Oct 1, 2026 | $27.40 | $27.735 | $26.72 | $26.93 | 1.18M |
| Sep 30, 2026 | $28.18 | $28.18 | $27.20 | $27.50 | 1.37M |
| Sep 29, 2026 | $27.96 | $28.25 | $27.40 | $28.04 | 920.84K |
| Sep 28, 2026 | $27.32 | $28.05 | $27.00 | $27.91 | 1.12M |
| Sep 25, 2026 | $27.85 | $28.38 | $27.43 | $28.09 | 1.15M |
| Sep 24, 2026 | $28.52 | $28.65 | $27.31 | $27.80 | 2.18M |
| Sep 23, 2026 | $29.41 | $29.78 | $28.085 | $28.51 | 2.46M |
| Sep 22, 2026 | $28.63 | $29.69 | $28.55 | $29.37 | 2.06M |
| Sep 21, 2026 | $28.33 | $29.14 | $28.31 | $28.37 | 1.49M |
| Sep 18, 2026 | $28.80 | $29.27 | $27.75 | $28.33 | 2.68M |
| Sep 17, 2026 | $28.63 | $29.08 | $28.16 | $28.81 | 1.55M |
| Sep 16, 2026 | $27.48 | $28.38 | $27.08 | $28.16 | 1.23M |
The latest Smart Investors Daily articles mentioning ACHC.
Company
Market Activity
Research & News
ACHC research
Company profile and research snapshot.
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The company's revenue is derived from services rendered to patients for inpatient psychiatric and substance abuse care, outpatient psychiatric care, and adolescent residential treatment.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 23, 2026 | Leerink Partners | Market Perform | — |
| Jul 30, 2026 | Guggenheim | Buy | — |
| Jul 30, 2026 | Barclays | Equal-Weight | — |
| Jul 20, 2026 | Guggenheim | Buy | — |
| Jul 14, 2026 | TD Cowen | Buy | — |
Generated Oct 14, 2026, 9:01 PM
Acadia Healthcare Company is gaining 4.76% today, reflecting modest positive momentum as the healthcare services provider navigates a complex market environment. The stock's movement appears driven by broader market sentiment rather than company-specific catalysts, with ACHC trading under $50 per share and facing a delicate balance between operational challenges and recovery opportunities.
Bottom line: ACHC's 4.76% gain reflects cautious optimism within a fundamentally challenged valuation setup, with the stock trading under $50 amid mixed institutional sentiment. Investors should view this as a transition point where execution on operational improvements and cost management will determine whether the stock sustains gains or faces renewed pressure.
Yahoo · Oct 12, 2026
Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline prices don’t guarantee quality, and investors should exercise caution as some have shaky business models.
Yahoo · Oct 8, 2026
Acadia Healthcare (ACHC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Yahoo · Oct 7, 2026
Acadia Healthcare trades at $28.83 and has moved in lockstep with the market. Its shares have returned 13.5% over the last six months while the S&P 500 has gained 17.5%.
Yahoo · Oct 5, 2026
Acadia Healthcare (ACHC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning ACHC.
